Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 [IFRS]

1. Consolidated financial results for the fiscal year ended March 31, 2025 (from April 1, 2024 to March 31, 2025)

2. Dividends per share

3. Consolidated forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)

■ Notes

1. Significant changes in the scope of consolidation for the fiscal year ended March 31, 2025 : Yes
   Included: - (-)
   Excluded: Three companies Ambry Genetics Corporation, Invicro, LLC, and Konica Minolta Business Associates Co., Ltd.
2. Changes in accounting policies or changes in accounting estimates

   a. Changes in accounting policies required by International
       Financial Reporting Standards (IFRS): None

   b. Changes in accounting policies other than the above a.: None

   c. Changes in accounting estimates: Yes

   (Note)For further details, refer to “4. CONSOLIDATED FINANCIAL STATEMENTS AND RELATED NOTES, (6) Notes to the Consolidated Financial Statements [Change in accounting estimates]” on page 28.

3. Number of issued and outstanding shares (common stock)

   a. Number of issued and outstanding shares (including treasury shares)
       As of March 31, 2025: 502,664,337 shares
       As of March 31, 2024: 502,664,337 shares

   b. Number of treasury shares
       As of March 31, 2025: 7,837,719 shares
       As of March 31, 2024: 8,180,129 shares

   c. Average number of issued and outstanding shares during the year
       The fiscal year ended March 31, 2025: 494,726,988 shares
       The fiscal year ended March 31, 2024: 494,297,126 shares

(Note)The Company has established the Board Incentive Plan. The shares owned by the trust account relating to this trust are accounted for as treasury shares (1,956,064 shares as of March 31, 2025, and 2,223,585 shares as of March 31, 2024).

(Reference) Overview of non-consolidated financial results

■ This summary of consolidated financial results falls outside the scope of audit procedures to be performed by certified public accountants or an audit firm.

■ Explanation concerning the appropriate use of the forecasts for results of operations and other special matters

(Note on the forecasts for the consolidated financial results)

The forecasts for results of operations in this report are based on information currently available to the Company and its subsidiaries (the “Group”) and certain assumptions determined to be reasonable, and are not intended to assure any achievement of the Group’s operations. Actual results may differ significantly from the forecasts due to various factors. For further details of the assumptions that form the basis of the forecasts and other related matters when referring to the forecasts, refer to “1. OVERVIEW OF FINANCIAL RESULTS, (1) Overview of Consolidated Operating Results, c. Performance Forecasts for the Fiscal Year Ending March 31, 2026” in the attached Supplementary Information on page 14

(Supplementary information for the financial results and briefing on the financial results)

The Company will hold a briefing on the financial results for institutional investors on Thursday, May 15, 2025. The proceedings and details of the briefing, along with the supplementary information on the financial results to be presented at the briefing, will be posted on the website of the Group soon after the briefing.